Gsa Capital Partners LLP Atri Cure, Inc. Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
A detailed history of Gsa Capital Partners LLP transactions in Atri Cure, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 32,206 shares of ATRC stock, worth $945,890. This represents 0.07% of its overall portfolio holdings.
Number of Shares
32,206
Previous 71,761
55.12%
Holding current value
$945,890
Previous $2.32 Million
54.43%
% of portfolio
0.07%
Previous 0.21%
Shares
25 transactions
Others Institutions Holding ATRC
# of Institutions
236Shares Held
51.9MCall Options Held
32.6KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.71MShares$138 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$136 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.68MShares$108 Million0.05% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3MShares$88.1 Million1.84% of portfolio
-
Macquarie Group LTD Australia, C32.44MShares$71.6 Million0.1% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.36B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...